A complete portfolio, formulated for effective patient outcomes
We offer a full range of premium raw products, active pharmaceutical ingredients, and finished products ready for market.
Everything we produce is guided by the same core principle: to help patients around the world access high-quality cannabis-based medicines that support real improvements in quality of life.
Our formulations have been developed by our own biochemists and pharmaceutical production experts, and are backed by years of scientific understanding and market experience. We work with global buyers and brands to supply targeted cannabinoid ingredients and ready-to-market products – helping them deliver effective outcomes for patients.
With trusted New Zealand supply, deep formulation expertise and an approach rooted in patient wellbeing, we help our partners bring products to the world that showcase the capabilities of medicinal cannabis.
"We’re biochemists and pharmaceutical producers ourselves, so every product we create for our customers is made to the same stringent standards we apply to our own. Our goal is to make it simple for brands to create premium cannabis medicines for their patients, with full confidence in the quality and consistency of the ingredients."
Blake Smith, Chief Science Officer.
Premium cannabis ingredients
Ora Pharm produces high-purity cannabis ingredients (APIs) for use in regulated medicinal and pharmaceutical products. We extract and refine cannabinoids to meet stringent international standards - providing our partners with consistent, compliant ingredients for a wide range of clinical applications.
Our API portfolio includes major cannabinoids such as CBD and THC, as well as minor cannabinoids like CBG, CBN, CBC and others. Each selected and formulated to meet the specific needs of patients and markets worldwide.
All ingredients are manufactured under GACP-compliant processes, with EU-GMP API certification underway, giving our partners full confidence in our quality, traceability and regulatory compliance.
Contact us to discuss your ingredient requirements.
"We’ve spent years developing formulations that truly work and dramatically improve quality of life for the patients that use them. These are products we stand behind, and that we’re proud to offer to global markets,"
Blake Smith, Chief Science Officer.
Targeted formulations for effective patient outcomes
We offer a portfolio of proprietary medicinal cannabis formulations - developed by our own team of biochemists, using our own IP, and designed to support the management of conditions where cannabis-based medicines can make a genuine difference to quality of life.
Our formulations have been highly effective in helping patients with seizures, sleep problems, pain and anxiety, among other conditions. They are backed by both scientific expertise and real-world therapeutic results. Every product has been carefully crafted to optimise cannabinoid and terpene profiles for targeted clinical outcomes, and is manufactured to the same stringent standards we apply across all of our production.
We offer these formulations in bulk formats, available for supply to trusted global brands looking to expand their medicinal cannabis offerings with proven, premium products.
Contact us to learn more about our proven medicinal cannabis formulated products.
"Our goal is to make it simple for our partner brands to bring premium cannabis medicines to patients - without needing to build their own manufacturing infrastructure,"
says Zoe Reece, Ora Pharm’s CEO.
Ready-to-market medicinal cannabis products, manufactured to global standards
We help global brands and buyers bring premium medicinal cannabis products to market - quickly, flexibly and at scale. Ora Pharm offers a range of sustainably produced finished products ready to be packaged and shipped.
Our portfolio includes:
- Tinctures - precisely formulated, shelf-stable oils for oral use
- Transdermal patches - controlled-release cannabinoid delivery
- Vape pods - high-purity formulations for inhalation
- Topical creams - cannabinoid-infused products for targeted relief
All finished products are produced under GACP-compliant processes, with full EU-GMP certification underway. We offer flexible packaging, white-label and contract manufacturing options - helping our partners meet market demand while reducing time-to-market and regulatory hurdles.
Contact us to explore our range of finished medicinal cannabis products.
"We’re here to help our brand partners succeed globally - our market and model makes that possible in ways most companies can’t match,"
Blake Smith, Chief Science Officer
Unlock new markets with private-label products
For global brands looking to expand into new markets, regulatory barriers often stand in the way — but that’s where we can help.
Through our private-label manufacturing services, Ora Pharm provides a complete pathway for brands to create exclusive new medicinal cannabis products, or replicate products they market in other countries. We work closely with global brand partners to develop formulations, tailored cannabinoid and terpene profiles, and distinctive packaging, customised to meet their requirements.
Our licensing under New Zealand’s favourable regulatory system creates an additional advantage: we can manufacture and export products into markets where many brand owners are restricted from shipping directly - including Australia, New Zealand, Canada and select European markets.
For US-based and other international brands navigating complex regulatory environments at home, this offers a powerful route to growth and new market access.
Our team brings deep expertise in formulation, quality control, packaging and branding, ensuring that every private-label development meets your specifications and global standards. We manage the full process from raw biomass through to finished, packaged product - with full compliance and confidentiality.
"A lot of great brands are held back by regulation in their home markets. We give them a way forward.”
Stuart Wilcox, Executive Chairman